MedPath

The effect of sulforaphane on depression in women with PCOS

Phase 2
Recruiting
Conditions
Severity of depression.
Polycystic ovarian syndrome
E28.2
Registration Number
IRCT20090117001556N144
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
50
Inclusion Criteria

Diagnosis of PCOS according to Rotterdam
Mild to moderate depression
18-40 years old
BMI = or > 25
High blood fat
Disruption of Glucose tolerance test

Exclusion Criteria

Smoking
Lactation or gestation
Metabolic or thyroid dysfunction
Hyperprolactinemia
Hypercortisolemia
Severe depression
CNS drugs used such as antidepressants or anxiolytics
Insulin administration
Uncontrolled blood glucose level
Intense physical activity
History of severe stress
Emotional failure or hospitalization in recent past
History of mental health problems in first-degree relatives

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Severity of depression. Timepoint: Baseline and weeks 6 & 12. Method of measurement: By Hamilton Depression Rating Scale (HDRS).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath